Although it is unclear if the cell type expressing the IDO enzyme may affect its ultimate immunologic impact in the setting of cancer, previous investigators have shown a relationship between local DC expression of IDO and poor clinical prognosis in patients with melanoma (28, 44). The gene discussed is IDO1; the disease is melanoma.